Yesterday, a Director at USANA Health (NYSE: USNA), Myron Wentz, bought shares of USNA for $1.35M.
This is Wentz’s first Buy trade following 19 Sell transactions. Following Myron Wentz’s last USNA Buy transaction on May 25, 2018, the stock climbed by 4.8%.
See today’s analyst top recommended stocks >>
Based on USANA Health’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $292 million and quarterly net profit of $28.95 million. In comparison, last year the company earned revenue of $255 million and had a net profit of $21.36 million. USNA’s market cap is $2.83B and the company has a P/E ratio of 41.21. Currently, USANA Health has an average volume of 164.1K.
Three different firms, including D.A. Davidson and Pivotal Research, currently also have a Buy rating on the stock.
In the last 30 days, insiders have sold $115.5M worth of USNA shares and purchased $2.7M worth of USNA shares. The insider sentiment on USANA Health has been negative according to 74 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science.
